FDA approves NuvaRing contraceptive implant.
D003270:Contraceptive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003274:Contraceptive Devices, Female; D017135:Desogestrel; D018795:Device Approval / Q000331:legislation & jurisprudence*; D004343:Drug Implants; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration; D014753:Vinyl Compounds / Q000008:administration & dosage / Q000009:adverse effects
D003270:Contraceptive Agents; D004343:Drug Implants; D014753:Vinyl Compounds; C044815:etonogestrel; D004997:Ethinyl Estradiol; D017135:Desogestrel